Jun Li from San Diego, CA, age 57

Professional Records

Medicine Doctors

Dr. Jun Li, West Covina CA - DDS (Doctor of Dental Surgery)

View page

Specialties:

Dentistry

Address:

2707 E Valley Blvd Suite 301, West Covina, CA 91792
(626) 435-1488 (Phone), (626) 435-1490 (Fax)

Languages:

English
Chinese

Jun Li, Diamond Bar CA

View page

Specialties:

Physician Assistant (PA)

Address:

1540 Bridgegate Dr, Diamond Bar, CA 91765
(626) 388-2390 (Phone)

Languages:

English

Jun Li

View page

Specialties:

Anatomic Pathology & Clinical Pathology

Work:

Hackensack Pathology Associates
30 Prospect Ave, Hackensack, NJ 07601
(551) 996-4816 (phone), (551) 996-2156 (fax)

Education:

Medical School
Nantong Med Coll, Nantong City, Jiangsu, China
Graduated: 1982

Languages:

English

Description:

Dr. Li graduated from the Nantong Med Coll, Nantong City, Jiangsu, China in 1982. He works in Hackensack, NJ and specializes in Anatomic Pathology & Clinical Pathology. Dr. Li is affiliated with Hackensack University Medical Center.

Jun Li

View page

Specialties:

Cardiovascular Disease

Work:

University Hospital Medical PhysiciansUniversity Hospitals Case Medical Center Cardiology
11100 Euclid Ave FL 3, Cleveland, OH 44106
(216) 844-7726 (phone), (216) 844-8954 (fax)

Languages:

English

Description:

Dr. Li works in Cleveland, OH and specializes in Cardiovascular Disease. Dr. Li is affiliated with University Hospitals Cleveland Medical Center.

Jun Li

View page

Specialties:

Anesthesiology
Psychiatry
Addiction Psychiatry

Education:

Tongji Medical University (1984)

Jun Li, Los Angeles CA

View page

Specialties:

Dentist

Address:

2010 Wilshire Blvd, Los Angeles, CA 90057
1313 W 8Th St, Los Angeles, CA 90017
2707 E Valley Blvd, West Covina, CA 91792

Jun Li, Diamond Bar CA

View page

Specialties:

Physician Assistant

Address:

1540 Bridgegate Dr, Diamond Bar, CA 91765

License Records

Jun Li

License #:

60435 - Active

Category:

Professional

Issued Date:

Jul 30, 2015

Expiration Date:

Sep 30, 2018

Lawyers & Attorneys

Jun Li - Lawyer

View page

Address:

Arc China, Inc.

Licenses:

New York - Currently registered 2007

Education:

University of Virginia School of Law

Jun Li - Lawyer

View page

Specialties:

Business Law
Commercial Law
Corporate Finance
Corporate Governance
Corporate Law
E-Commerce and Technology Law
Entrepreneurial Business Law
Internet
Mergers and Acquisitions
Securities Law
Technology and Science
Commercial
Securities Offerings
Life Sciences & Biotechnology

ISLN:

916473011

Admitted:

2001

University:

Carson-Newman College, M.A., 1989; University of Tennessee-Knoxville, Ph.D., 1996; Zhengzhou University-People's Republic of China, B.A., 1985

Law School:

Mercer University-Macon, J.D., 2001

Resumes

Jun Jun Li Temple City, CA

View page

Work:

Queen

2006 to 2000
Warehouse Manager

Education:

Pasadena City College
Pasadena, CA
2005
Associated in Nursing

Skills:

Ability to work independently.<br/>Strong communication skills. <br/>Excellent time management skills.

Jun Li US

View page

Work:

JBC and FASEB J

2004 to 2000
JBC and FASEB J

2013 to 2013
JBC and FASEB J

2012 to 2012
Cycle

2011 to 2011
Pei D

2010 to 2010
JBC and FASEB J

2007 to 2007
JBC and FASEB J

2006 to 2006
Co-first author
Biotechnol

1974 to 1974
Chemosphere

1965 to 1965
Immunology Institute

Associate Professor

Education:

Tsinghua University
Aug 2004 to Jul 2007
Ph.D. in Biochemistry and Molecular Biology
Third Military Medical University
Aug 2001 to Jul 2004
M.S. in Environmental Hygiene
Third Military Medical University
Aug 1998 to Jul 2001
bachelor in Clinic medicine

Business Records

Name / Title

Company / Classification

Phones & Addresses

Ms. Jun Li
Owner

Bridal Shoes Canada
Shoes - Retail

137 Dunoon Drive, Maple, ON L6A 1Z2
(888) 866-4246, (647) 426-3771

Jun Li
Vice President

Jun Li
Industrial Machinery and Equipment

1164 1 2 West Adams Blvd, Los Angeles, CA 90007

Jun Li
President

Natural Miya Inc

500 N Willowbrook Ave, Compton, CA 90220
820 S Garfield Ave, Alhambra, CA 91801

Jun Li
Owner

Bridal Shoes Canada
Shoes - Retail

(888) 866-4246, (647) 426-3771

Jun Li
President

Yiwu Junc Import & Export Hong

23555 Golden Spg Dr, Pomona, CA 91765

Jun Li
President

Gardena Restaurants Inc

1636 W Redondo Bch Blvd, Gardena, CA 90247
1119 S Gladys Ave, San Gabriel, CA 91776

Jun Zhi Li
President

American Perrigo Pharmaceutical Inc
Drug Stores and Proprietary Stores · Nonclassifiable Establishments

23 Dartmouth, Irvine, CA 92612

Jun Rui Li
President

Lyh Biz Group, Inc

1525 Prospect Ave, San Gabriel, CA 91776
2276 Foothill Blvd, La Verne, CA 91750

Inhibitors Of Cathepsin S

View page

US Patent:

7109243, Sep 19, 2006

Filed:

Mar 23, 2004

Appl. No.:

10/807612

Inventors:

Hong Liu - San Diego CA, US
David Tully - San Diego CA, US
Robert Epple - San Diego CA, US
Badry Bursulaya - San Diego CA, US
Jennifer Williams - La Jolla CA, US
Arnab Chatterjee - Encinitas CA, US
Jennifer Leslie Harris - San Diego CA, US
Jun Li - San Diego CA, US

Assignee:

IRM LLC - Hamilton

International Classification:

A01N 47/28

US Classification:

514595, 5142375, 514249, 514275, 514279, 51425501, 514330, 514355, 514364, 514359, 514406, 514394, 514422, 514416, 514448, 514459, 514471, 514472, 514602, 514603, 514604, 514522, 514596, 514598, 544165, 544231, 544332, 544312, 544391, 546226, 546316, 548131, 548255, 5482694, 5483044, 5483741, 548492, 548517, 548560

Abstract:

The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme (e. g. , cathespin K). The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.

Inhibitors Of Cathepsin S

View page

US Patent:

7384970, Jun 10, 2008

Filed:

Mar 23, 2004

Appl. No.:

10/807613

Inventors:

Hong Liu - San Diego CA, US
Phil Alper - Poway CA, US
Arnab Chatterjee - Encinitas CA, US
David Tully - San Diego CA, US
Badry Bursulaya - San Diego CA, US
David Woodmansee - San Diego CA, US
Robert Epple - San Diego CA, US
Jennifer Leslie Harris - San Diego CA, US
Jun Li - San Diego CA, US

Assignee:

IRM LLC - Hamilton

International Classification:

A61K 31/4045
C07D 209/08

US Classification:

514415, 548491

Abstract:

The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.

Providing A Downlink Control Structure In A First Carrier To Indicate Control Information In A Second, Different Carrier

View page

US Patent:

8520621, Aug 27, 2013

Filed:

Nov 4, 2009

Appl. No.:

13/125199

Inventors:

Lai-King Tee - San Diego CA, US
Yi Song - Plano TX, US
Jun Li - Richardson TX, US
Yuqiang Tang - Plano TX, US
Neng Wang - Plano TX, US

Assignee:

Apple Inc. - Cupertino CA

International Classification:

H04W 4/00

US Classification:

370329

Abstract:

A mobile station receives a downlink control structure in a first carrier, where the downlink control structure indicates that control information for the mobile station is on a second, different carrier. The mobile station decodes the control information in the second carrier, where the control information specifies resource allocation of a wireless link for the mobile station. More specifically, according to some implementations, the control channel in the first carrier specifies the resource allocation for an extended control channel in the second carrier, where the extended control channel specifies the resource allocation for traffic data of a wireless link for the mobile station.

Hepsin Substrates And Prodrugs

View page

US Patent:

20040009911, Jan 15, 2004

Filed:

Jan 31, 2003

Appl. No.:

10/356656

Inventors:

Jennifer Harris - San Diego CA, US
Bradley Backes - Chicago IL, US
Jun Li - San Diego CA, US
David Tully - San Diego CA, US

Assignee:

IRM, LLC - Hamilton

International Classification:

A61K038/10
A61K038/08
C07K007/08
C07K007/06

US Classification:

514/012000, 514/013000, 514/014000, 514/015000, 514/016000, 514/017000, 530/324000, 530/325000, 530/326000, 530/327000, 530/328000, 530/329000, 530/330000

Abstract:

Substrate specificity profiles are used to determine optimal hepsin substrate sequences, both to the prime side and non-prime side of the hepsin recognition site. The hepsin substrate sequences are used in designing substrates, inhibitors, and prodrugs. For example, prodrugs are provided for use in the treatment of prostate cancer. Hepsin inhibitors based on substrate specificity are also provided.

Methods For Identifying Compounds With Thrapeutic Potential For Treatment Of Central Neurodegenerative Diseases Resulting From Abnormal Protein Or Peptide Accumulation

View page

US Patent:

20040233833, Nov 25, 2004

Filed:

Jun 1, 2004

Appl. No.:

10/480608

Inventors:

Martin Rechsteiner - Salt Lake City UT, US
Gregory Pratt - Salt Lake City UT, US
Jun Li - San Diego CA, US

International Classification:

G11B005/02

US Classification:

369/292000

Abstract:

The invention provides a mutant activator of a 20S proteasome. More specifically, relates to a mutant activator comprising a mutant REG protein that promotes the 20S proteasome to cleave protein or peptide substrates. The invention also provides a methods of screening for compounds that inhibit or enhance REG activated 20S proteosomal cleavage and method of treating subjects with neurodegenerative diseases characterized by an accumulation of abnormal protein or peptide.

Flavivirus Protease Substrates And Inhibitors

View page

US Patent:

20080032917, Feb 7, 2008

Filed:

Jan 2, 2007

Appl. No.:

11/619155

Inventors:

Jun Li - San Diego CA, US
Jennifer Harris - San Diego CA, US
Christine Tumanut - Spring Valley CA, US

Assignee:

IRM LLC, A DELAWARE LIMITED LIABILITY COMPANY - Hamilton

International Classification:

A61K 38/00
C07K 2/00
C07K 5/00
C07K 7/00
C12N 5/00

US Classification:

514002000, 435375000, 530300000, 530328000, 530330000

Abstract:

The invention provides substrate specificity profiles for flaviviral proteases (e.g., dengue proteases or West Nile protease). Optimal flaviviral protease substrate sequences, both to the prime side and non-prime side of the flaviviral protease recognition site, are disclosed herein. The flaviviral protease substrate sequences are used in designing substrates, inhibitors, and prodrugs. Flaviviral protease inhibitors based on substrate specificity are also provided.

Inhibitors Of Cathepsin S

View page

US Patent:

20080242671, Oct 2, 2008

Filed:

Mar 25, 2008

Appl. No.:

12/055154

Inventors:

Hong Liu - San Diego CA, US
Phillip Alper - San Diego CA, US
Arnab Chatterjee - Encinitas CA, US
David Tully - San Diego CA, US
Badry Bursulaya - San Diego CA, US
David Woodmansee - Basel, CH
Robert Epple - San Diego CA, US
Jennifer Leslie Harris - San Diego CA, US
Jun Li - San Diego CA, US

Assignee:

IRM LLC - Hamilton

International Classification:

A61K 31/501
A61K 31/165
C07C 233/63
A61K 31/454
C07D 401/12
C07D 209/04
A61K 31/404
C07D 401/14

US Classification:

51425203, 564157, 514616, 514323, 546201, 548469, 514415, 544238

Abstract:

The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.

Pcsk9 Antagonists

View page

US Patent:

20110142849, Jun 16, 2011

Filed:

Dec 10, 2010

Appl. No.:

12/965743

Inventors:

SARAH RUE - SAN DIEGO CA, US
STEVE B. COHEN - SAN DIEGO CA, US
JUN LI - SAN DIEGO CA, US
DAVID YOWE - BELMONT MA, US

Assignee:

IRM LLC - HAMILTON
NOVARTIS AG - BASEL

International Classification:

A61K 39/395
C07K 16/40
A61P 3/06
A61P 9/10

US Classification:

4241581, 5303873, 5303898

Abstract:

The present invention provides antibody antagonists against proprotein convertase subtilisin/kexin type 9a (“PCSK9”) and methods of using such antibodies.

Videos & Images